Hyland Inter-office memo regarding being aware of the fact that Behring were in the last stages of clinical trials of "hepatitis risk-free" AHF.
Linked evidence
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates